For the quarter ending 2025-11-30, BMRA made $1,210K in revenue. -$1,321K in net income. Net profit margin of -109.17%.
| Income Statement | 2025-11-30 | 2025-08-31 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|
| Net sales | 1,210 | 1,380 | 1,636 | 1,807 |
| Cost of sales | 1,159 | 956 | 1,199 | 1,518 |
| Gross profit | 51 | 424 | 437 | 289 |
| Selling, general and administrative | 1,231 | 1,330 | 1,173 | 1,360 |
| Research and development | 193 | 212 | 257 | 297 |
| Total operating expenses | 1,424 | 1,542 | 1,430 | 1,657 |
| Loss from operations | -1,373 | -1,118 | -993 | -1,368 |
| Dividend, interest, and other income | 58 | 1,123 | 40 | 56 |
| Total other income | 58 | 1,123 | 40 | 56 |
| Loss before income taxes | -1,315 | 5 | -953 | -1,312 |
| Provision for income taxes | 5 | 3 | -3 | 4 |
| Net loss | -1,320 | 2 | -950 | -1,316 |
| Foreign currency translation | -1 | 2 | -4 | -6 |
| Comprehensive loss | -1,321 | 4 | -954 | -1,322 |
| Basic | 2,908,164 | 2,638,699 | 17,121,436 | 16,821,646 |
| Basic net loss per common share | -0.45 | 0 | -0.06 | -0.08 |
| Diluted | 2,908,164 | 2,638,699 | 17,121,436 | 16,821,646 |
| Diluted net loss per common share | -0.45 | 0 | -0.06 | -0.08 |
BIOMERICA INC (BMRA)
BIOMERICA INC (BMRA)